drug
tivozanib hydrochloride
Marketedupdated 4mo agoby AVEO Pharmaceuticals Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying tivozanib hydrochloride
Patent cliff
source: FDA Orange Bookfirst barrier falls
Nov 16, 2028
~2.2 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Nov 5, 2039method-of-use (U-3476)US 11504365
- Nov 5, 2039method-of-use (U-3476)US 11504365
- Nov 16, 2028compositionUS 71667222.2y
- Nov 16, 2028compositionUS 71667222.2y
FDA exclusivities (2)
- Mar 10, 2026NCENew Chemical Entity (5y)
- Mar 10, 2026NCENew Chemical Entity (5y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that